Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 5/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17117806 | 1.00 | TYMS (0.74) | TYMS | |
| SCHEMBL3235048 | 1.00 | TYMS (0.74) | TYMS | |
| SCHEMBL2409753 | 0.93 | TYMS (0.65) | TYMS | |
| SCHEMBL12758622 | 0.93 | TYMS (0.65) | TYMS | |
| SCHEMBL19389397 | 0.91 | TYMS (0.63) | TYMS | |
| SCHEMBL12758590 | 0.91 | TYMS (0.63) | TYMS | |
| Triphosphate SCHEMBL7631515 | 0.90 | TYMS (0.62) | TYMS | |
| SCHEMBL1163795 | 0.90 | TYMS (0.62) | TYMS | |
| SCHEMBL13551342 | 0.90 | TYMS (0.62) | TYMS | |
| SCHEMBL150029 | 0.90 | TYMS (0.62) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11293063-B2 | Pooled adapter strategy for reducing bias in small RNA characterization | MOUNT SINAI SCHOOL OF MEDICINE (US) | 2022-04-05 | — | — | US | claimed |
| US-20200172972-A1 | POOLED ADAPTER STRATEGY FOR REDUCING BIAS IN SMALL RNA CHARACTERIZATION | MOUNT SINAI SCHOOL OF MEDICINE | 2020-06-04 | — | — | US | claimed |
| US-20190175760-A1 | METHODS OF TREATING A SUBJECT HAVING GLYCOGEN STORAGE DISEASE WITH mRNA ENCODING GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT (G6PC) | CUREVAC AG (DE) | 2019-06-13 | — | — | US | claimed |
| US-20190175756-A1 | METHODS OF TREATING A SUBJECT HAVING GLYCOGEN STORAGE DISEASE II WITH mRNA ENCODING ACID GLUCOSIDASE ALPHA (GAA) | CUREVAC AG (DE) | 2019-06-13 | — | — | US | claimed |
| US-20190175757-A1 | METHODS OF TREATING A SUBJECT HAVING FRIEDREICH'S ATAXIA WITH mRNA ENCODING FRATAXIN | CUREVAC AG (DE) | 2019-06-13 | — | — | US | claimed |
| US-20190175759-A1 | METHODS OF TREATING A SUBJECT HAVING PROPIONIC ACIDEMIA WITH mRNA ENCODING PROPIONYL-COA CARBOXYLASE, SUBUNIT ALPHA AND/OR BETA (PCCA AND/OR PCCB) | CUREVAC AG (DE) | 2019-06-13 | — | — | US | claimed |
| US-20190175758-A1 | METHODS OF TREATING A SUBJECT HAVING CITRULLINEMIA WITH mRNA ENCODING ARGININOSUCCINATE SYNTHASE (ASS) | CUREVAC AG (DE) | 2019-06-13 | — | — | US | claimed |
| US-20190167808-A1 | METHODS OF TREATING PHENYLKETONURIA WITH MRNA ENCODING PHENYLALANINE HYDROXYLASE (PAH) | CUREVAC AG (DE) | 2019-06-06 | — | — | US | claimed |
| US-20190167809-A1 | METHODS OF TREATING A SUBJECT WITH mRNA ENCODING COAGULATION FACTOR VIII (F8) | CUREVAC AG (DE) | 2019-06-06 | — | — | US | claimed |
| US-20180311379-A1 | COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION | CUREVAC AG (DE) | 2018-11-01 | — | — | US | claimed |
| US-20170000858-A1 | COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION | CUREVAC AG (DE) | 2017-01-05 | — | — | US | claimed |
| US-20160367704-A1 | COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION | CUREVAC AG (DE) | 2016-12-22 | — | — | US | claimed |
| US-9487825-B2 | Pooled adapter strategy for reducing bias in small RNA characterization | MOUNT SINAI SCHOOL OF MEDICINE (US) | 2016-11-08 | — | — | US | claimed |
| US-20160184406-A1 | COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION | CUREVAC AG (DE) | 2016-06-30 | — | — | US | claimed |
| US-20120322691-A1 | POOLED ADAPTER STRATEGY FOR REDUCING BIAS IN SMALL RNA CHARACTERIZATION | MOUNT SINAI SCHOOL OF MEDICINE | 2012-12-20 | — | — | US | claimed |
| WO-2012158603-A2 | POOLED ADAPTER STRATEGY FOR REDUCING BIAS IN SMALL RNA CHARACTERIZATION | BIOO SCIENTIFIC CORPORATION (US) | 2012-11-22 | — | — | WO | claimed |
| US-8097405-B1 | Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs | ENZO BIOCHEM, INC. (US) | 2012-01-17 | — | — | US | claimed |
| WO-2009127230-A1 | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION | CUREVAC GMBH (DE) | 2009-10-22 | — | — | WO | claimed |
| US-6992180-B1 | Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2006-01-31 | — | — | US | claimed |
| US-5985266-A | SENSITIZE TUMORS, RETROVIRUS COMPRISES OPERATIVELY LINKED TO A PROMOTER A GENE ENCODING A VIRAL THYMIDINE KINASE; SUCH THAT SAID TUMOR CELLS BECOME TRANSDUCED BY SAID RETROVIRUS AND EXPRESS SAID VIRAL THYMIDINE KINASE GENE; | HUMAN GENE THERAPY RESEARCH INSTITUTE (US) | 1999-11-16 | — | — | US | claimed |